Published on in Vol 22, No 9 (2020): September
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/16053, first published
.
Journals
- Jackson M, Ahmann A, Shah V. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2021;23(S1):S-27 View
- Chu P. Continuous Glucose Monitoring Use and Access Disparities. JAMA 2021;326(14):1438 View
- Brannon G, Ray M, Cho P, Baum M, Beg M, Bevers T, Schembre S, Basen-Engquist K, Liao Y. A qualitative study to explore the acceptability and usefulness of personalized biofeedback to motivate physical activity in cancer survivors. DIGITAL HEALTH 2022;8:205520762211290 View
- Mounié M, Costa N, Gourdy P, Latorre C, Schirr-Bonnans S, Lagarrigue J, Roussel H, Martini J, Buisson J, Chauchard M, Delaunay J, Taoui S, Poncet M, Cosma V, Lablanche S, Coustols-Valat M, Chaillous L, Thivolet C, Sanz C, Penfornis A, Lepage B, Colineaux H, Hanaire H, Molinier L, Turnin M. Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Study. Diabetes Therapy 2022;13(4):693 View
- Dabbagh Z, McKee M, Pirraglia P, Clements K, Liu F, Amante D, Shukla P, Gerber B. The Expanding Use of Continuous Glucose Monitoring in Type 2 Diabetes. Diabetes Technology & Therapeutics 2022;24(7):510 View
- Yapanis M, James S, Craig M, O’Neal D, Ekinci E. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring. The Journal of Clinical Endocrinology & Metabolism 2022;107(6):e2221 View
- Igarashi A, Maruyama-Sakurai K, Kubota A, Akiyama H, Yajima T, Kohsaka S, Miyata H. Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan. Diabetes Therapy 2022;13(7):1367 View
- Ben-Assuli O. Measuring the cost-effectiveness of using telehealth for diabetes management: A narrative review of methods and findings. International Journal of Medical Informatics 2022;163:104764 View
- Lee S, Lee S, Kim K, Shin J. Usefulness of continuous glucose monitoring of blood glucose control in patients with diabetes undergoing hemodialysis: A pilot study. Frontiers in Medicine 2023;10 View
- Nie L, Oldenburg B, Cao Y, Ren W. Continuous usage intention of mobile health services: model construction and validation. BMC Health Services Research 2023;23(1) View
- Willems R, Annemans L, Siopis G, Moschonis G, Vedanthan R, Jung J, Kwasnicka D, Oldenburg B, d’Antonio C, Girolami S, Agapidaki E, Manios Y, Verhaeghe N, Usheva N, Iotova V, Triantafyllidis A, Votis K, Toti F, Makrilakis K, Seghieri C, Moreno L, Dupont S, Lewis L, Djokic D, Skouteris H. Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension. npj Digital Medicine 2023;6(1) View
- Tornvall I, Kenny D, Wubishet B, Russell A, Menon A, Comans T. Economic Evaluations of mHealth Interventions for the Management of Type 2 Diabetes: A Scoping Review. Journal of Diabetes Science and Technology 2023 View
- Mohiuddin S, Ward M, Hollingworth W, Watson J, Whiting P, Thom H. Cost-Effectiveness of Routine Monitoring of Long-Term Conditions in Primary Care: Informing Decision Modelling with a Systematic Review in Hypertension, Type 2 Diabetes and Chronic Kidney Disease. PharmacoEconomics - Open 2024;8(3):359 View
- Castillo-Valdez P, Rodriguez-Salvador M, Ho Y. Scientific Production Dynamics in mHealth for Diabetes: Scientometric Analysis. JMIR Diabetes 2024;9:e52196 View
- Sakane N, Matsuhisa M, Kuroda A, Miura J, Hirota Y, Kato K, Toyoda M, Kouyama R, Kouyama K, Shimada A, Kawashima S, Matoba Y, Meguro S, Kusunoki Y, Hida K, Tanaka T, Domichi M, Suganuma A, Suzuki S, Tone A, Hosoda K, Murata T. Cost-effective analysis focused on hypoglycemia of intermittent-scanning continuous glucose monitoring in type 1 diabetes adults: a ISCHIA randomized clinical trial. Diabetology International 2024 View